Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Discover ways to build wealth quickly with low investment strategies that maximize your returns. Start growing your wealth today!
25,339 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Wine stocks rallied on optimism around premium wine demand and stronger consumer spending. Analysts say premiumizatio...
As AI moves from model training to real-time inference, one chipmaker looms large for investors. This story explains ...
Celebrity wellness stories grab headlines, but behind the flash are real costs and tricky choices. This article break...
Circle Internet Group posted a stronger-than-expected Q1 2026, triggering a 68% year-to-date gain and a rally that ou...
Twilio’s CFO applies a GE-style, operator-driven playbook to guide a mid-turnaround as the company doubles down on AI...
JPMorgan researchers warn that ether and other altcoins could keep lagging Bitcoin without clearer growth in on-chain...
MBA Chief Bob Broeksmit calls for relief from cost-adding rules as mortgage rates remain elevated, urging targeted re...
A tech leader argues AI will not replace workers, sparking a debate as employers weigh productivity gains against fea...
A new AI platform launch aims to empower independent brokerages to stay independent, compete scale, and win at scale ...
RLUSD on the XRP Ledger crosses a $1.7 billion market cap while XRP trades in a narrow band, fueling questions about ...
Dollar Tree beats expectations and lifts its full-year outlook, sending DLTR up sharply as the discount-store rally w...